Return to your complete original selection. This free page shows its own public coverage.
Monthly · USD · Source: GACC · Data through 2026-09
Preview available records and price before you buy.
Advanced selectionHS 300490 · All partner countries
| Year | Export value |
|---|---|
| 2026 Jan–Sep | $2.8B |
| 2025 · Full year | $3.5B |
| 2024 · Full year | $3.3B |
| 2023 · Full year | $3.2B |
| 2022 · Full year | $3.4B |
| Year | Export value |
|---|---|
| 2021 · Full year | $3.3B |
Jan–Sep 2026 vs Jan–Sep 2025 · USD
September 2026 · USD
| Partner | Value | Share |
|---|---|---|
| United States | $103.3M | 28.5% |
| Australia | $34.7M | 9.6% |
| Hong Kong | $20.3M | 5.6% |
| Poland | $11.4M | 3.1% |
| South Korea | $11.2M | 3.1% |
2021-01 to 2026-09 · USD
| Partner | Value | Share |
|---|---|---|
| United States | $4.5B | 23.3% |
| Australia | $1.5B | 7.6% |
| Hong Kong | $1.4B | 7.2% |
| Poland | $626M | 3.2% |
| South Korea | $1.1B | 5.6% |
China customs reports HS 300490 at the 8-digit level. 9 subheadings are published under it. Select an HS8 subcode to check supported export coverage, samples and your one-time price, then buy online. For unsupported scopes or custom research, ask for optional custom help.
Sulfonamide-based pharmaceutical preparations formulated into retail packages or measured doses for therapeutic or prophylactic application.
Therapeutic or prophylactic preparations utilizing biphenyl dicarboxylate as the active ingredient, supplied in retail packings or measured doses.
Traditional Chinese medicinal liquors and wines prepared with herbal ingredients, packaged for retail sale or dispensed in measured therapeutic doses.
The specific traditional Chinese compound formula known as Pien Tze Huang, packaged for retail sale or provided in measured doses.
The traditional Chinese herbal formulation recognized as Bai Yao, prepared for retail sale or dispensed in individually measured doses.
Topical essential balm formulated for therapeutic use, packaged for retail sale or contained in measured doses for prophylactic application.
Retail-packaged or dose-measured Angong niuhuang wan, a specific traditional Chinese medicinal formulation used for therapeutic or prophylactic purposes.
Traditional Chinese medicinal preparations for retail sale or measured dosing, excluding the specifically classified Angong niuhuang wan formulation.
Pharmaceutical preparations for therapeutic or prophylactic retail sale that do not fall under Chinese-type medicines or other specifically named categories.
HS 300490 · China exports
| month | value_usd | hs_code | year | flow | partner_code | country_name |
|---|---|---|---|---|---|---|
| 2023-12 | 356,262 | 300490 | 2023 | export | 221 | Guinea |
| 2023-11 | 516,404 | 300490 | 2023 | export | 221 | Guinea |
| 2023-10 | 129,049 | 300490 | 2023 | export | 221 | Guinea |
| 2023-09 | 93,163 | 300490 | 2023 | export | 221 | Guinea |
| 2023-08 | 99,341 | 300490 | 2023 | export | 221 | Guinea |
| month | value_usd | hs_code | year | flow | partner_code | country_name |
|---|---|---|---|---|---|---|
| 2023-12 | 356,262 | 300490 | 2023 | export | 221 | Guinea |
| 2023-11 | 516,404 | 300490 | 2023 | export | 221 | Guinea |
| 2023-10 | 129,049 | 300490 | 2023 | export | 221 | Guinea |
| 2023-09 | 93,163 | 300490 | 2023 | export | 221 | Guinea |
| 2023-08 | 99,341 | 300490 | 2023 | export | 221 | Guinea |
| 2023-07 | 26,908 | 300490 | 2023 | export | 221 | Guinea |
| 2023-06 | 155,632 | 300490 | 2023 | export | 221 | Guinea |
| 2023-05 | 311,673 | 300490 | 2023 | export | 221 | Guinea |
| 2023-04 | 212,487 | 300490 | 2023 | export | 221 | Guinea |
| 2023-03 | 103,877 | 300490 | 2023 | export | 221 | Guinea |
| 2023-02 | 211,517 | 300490 | 2023 | export | 221 | Guinea |
| 2023-01 | 1,378,026 | 300490 | 2023 | export | 221 | Guinea |
China exported $2.8B of medicaments (HS 300490) during January–September 2026. In September 2026 alone, China exported $362.3M of medicaments, up 22.2% from September 2025. Retail-packaged pharmaceutical drugs and medicines intended for treatment or disease prevention, capturing formulations not specifically classified elsewhere such as antibiotics, vitamins, or hormones. The page covers January 2021 to September 2026. Values are in US dollars, from the China General Administration of Customs (GACC).
In September 2026, United States, Australia, Hong Kong were among the leading destinations shown, together accounting for 43.7% of that month's trade value. These are monthly figures, not a full-year ranking.
China's medicaments exports were up 7.7% from January–September 2025, reaching $2.8B during January–September 2026.
Preview and buy a monthly medicaments export CSV for your selected products, countries and years, including available HS8 detail. The file preview and price are shown before payment.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
China Data Portal. "China Medicaments (HS 300490) Export Data." https://chinadata.live/china-trade/hs/300490/